Ultrasound guided versus blinded injection in trigger finger treatment: a prospective controlled study

dc.authoridTuncez, Mahmut/0000-0002-4985-5021
dc.authoridTuran, Kaya/0000-0002-0547-995X
dc.authorwosidTuncez, Mahmut/AEL-3137-2022
dc.authorwosidTuran, Kaya/AGA-7891-2022
dc.contributor.authorTuncez, Mahmut
dc.contributor.authorTuran, Kaya
dc.contributor.authorAydin, Ozgur Dogan
dc.contributor.authorTuncez, Hulya Cetin
dc.date.accessioned2024-05-19T14:47:07Z
dc.date.available2024-05-19T14:47:07Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.description.abstractBackgroundTrigger finger is a common disease with a lifetime prevalence of 2%. One of the frequently preferred non-surgical treatments is blinded injection around the A1 pulley. This study aims to compare the clinical results of ultrasound-guided and blinded corticosteroid injection in the trigger finger.MethodsIn this prospective clinical study, 66 patients who had persistent symptoms of a single trigger finger were included. Patients with similar baseline characteristics such as age, gender, triggering period, and comorbidities were randomized. 34 patients had ultrasound-guided (UG), and 32 had blinded injections (BG). QDASH, VAS, time to return to work, and complications were compared between the groups.ResultsThe mean age was 52,66 (29-73) years. There were 18 male and 48 female patients. In the UG, the triggering resolved faster, returning to work was earlier, and the medication period was shorter (p < 0.05). A total of 17 patients who had diabetes mellitus received re-injections, 11 of which were in BG and 6 in UG (p < 0.05). Although statistically significantly lower scores were obtained in UG at the 1st and 4th weeks in the QDASH and VAS scores (p < 0.05), at the 12th and 24 weeks, there was no significant difference (p > 0.05).ConclusionUsing ultrasound guidance for corticosteroid injections is more effective for treating trigger fingers than the blinded method, leading to better results and a faster return to work in the early stages of treatment.en_US
dc.identifier.doi10.1186/s13018-023-03950-y
dc.identifier.issn1749-799X
dc.identifier.issue1en_US
dc.identifier.pmid37365603en_US
dc.identifier.scopus2-s2.0-85163376596en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org10.1186/s13018-023-03950-y
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5654
dc.identifier.volume18en_US
dc.identifier.wosWOS:001016770300001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherBmcen_US
dc.relation.ispartofJournal of Orthopaedic Surgery and Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240519_kaen_US
dc.subjectTrigger Fingeren_US
dc.subjectSteroid Injectionen_US
dc.subjectUltrasound Guided Injectionen_US
dc.titleUltrasound guided versus blinded injection in trigger finger treatment: a prospective controlled studyen_US
dc.typeArticleen_US

Dosyalar